Profile and potential of ixabepilone in the treatment of pancreatic cancer
Brandon G Smaglo, Michael J PishvaianLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USAAbstract: The management of metastatic pancreatic adenocarcinoma is a challenge for medical oncologists because of both the aggressive nature of the disease and the relative paucity...
Main Authors: | Smaglo BG, Pishvaian MJ |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-07-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/profile-and-potential-of-ixabepilone-in-the-treatment-of-pancreatic-ca-peer-reviewed-article-DDDT |
Similar Items
-
Ixabepilone as Monotherapy or in Combination with Capecitabine for the Treatment of Advanced Breast Cancer
by: Katherine H. Rak Tkaczuk
Published: (2011-01-01) -
Ixabepilone as Monotherapy or in Combination with Capecitabine for the Treatment of Advanced Breast Cancer
by: Katherine H. Rak Tkaczuk
Published: (2011-01-01) -
Advancements in the Treatment of Metastatic Breast Cancer (MBC): The Role of Ixabepilone
by: Massimo Cristofanilli
Published: (2012-01-01) -
Ixabepilone: new perspectives for its use in breast cancer
by: A. A. Mescheryakov, et al.
Published: (2018-11-01) -
Ixabepilone: Overview of Effectiveness, Safety, and Tolerability in Metastatic Breast Cancer
by: Nuhad K. Ibrahim
Published: (2021-07-01)